Dr. Jason C. Stepp, MD

Dr. Stepp practices at West Penn Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Dr. Stepp's NPI, 1124226311, was assigned on July 10, 2007. Dr. Stepp graduated from University of Oklahoma College of Medicine in 2007. Dr. Stepp holds Pennsylvania license MD440227.

Dr. Stepp's primary practice is West Penn Hospital, at 4800 Friendship Avenue, Pittsburgh, PA 15224 in Allegheny County. The practice phone is (412) 578-5000.

Dr. Stepp's primary practice is West Penn Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Dr. Stepp is also affiliated with Allegheny General Hospital. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Stepp to 3 more hospitals, 1 group practice or clinic, 1 hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stepp practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Stepp's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Stepp is board certified in medical oncology by the American Board of Internal Medicine. Dr. Stepp is licensed in Pennsylvania.

CMS data shows 794 Medicare services from Dr. Stepp across 12 procedure codes in 2024, for 260 Medicare patients. Medicare paid $60,244 for them.

CMS counts 260 Medicare patients who saw Dr. Stepp in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stepp's median patient age at 72, with 53% women.

In 2024, Dr. Stepp wrote 1,172 Medicare Part D claims for 211 patients. 79% of them were for generic drugs. CMS names the drug for 892 of them, across 24 drugs with 11 or more claims each, at $1,002,671 in total drug cost. In 2023, CMS named 724 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Stepp for performance year 2024, reported as part of a group. Dr. Stepp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stepp as offering telehealth.

CMS Open Payments shows 96 general payments to Dr. Stepp from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Astellas Pharma US Inc paid the most, $322.

Dr. Stepp graduated from University of Oklahoma College of Medicine in 2007.